HIF-1α suppresses myeloma progression by targeting Mcl-1

被引:1
作者
Wu, Feng [1 ]
Tong, Dong-Dong [2 ]
Ni, Lei [2 ]
Wang, Lu-Min [2 ]
Wang, Meng-Chang [3 ]
机构
[1] Xi An Jiao Tong Univ, Ctr Teaching & Expt Med Post Grad, Sch Med, Xian, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Cell Biol & Genet, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hematol, Xian, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
HIF-1; alpha; Mcl-1; MMs; proliferation; apoptosis; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER; CELLS; PROLIFERATION; APOPTOSIS; PATHWAY; VEGF;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HIF-1 alpha is involved in the carcinogenesis and progression of multiple types of cancer. However, the precise role of HIF-1 alpha is unclear in multiple myeloma. Through the qRT-PCR and CCK-8 assays, we demonstrated that silenc-ing the expression of HIF-1 alpha and Mcl-1, MM proliferation can be decreased and apoptosis can be induced. Next, using the GEO database, we found that Mcl-1 was increased in MMs. Mcl-1 overexpression counterbalanced the tumor suppressing effect of siHIF-1 alpha on MM apoptosis. Additionally, HIF-1 alpha acting as a transcription factor, could directly target the promoter region of Mcl-1 to promote Mcl-1 expression. Based on the experimental result, our find-ings strongly suggest that HIF-1 alpha regulated the progression of MMs by directly targeting the Mcl-1.
引用
收藏
页码:1483 / +
页数:10
相关论文
共 29 条
[1]   MiR-200c downregulates HIF-1 and inhibits migration of lung cancer cells [J].
Byun, Yuree ;
Choi, Young-Chul ;
Jeong, Yunhui ;
Lee, Gangtae ;
Yoon, Sena ;
Jeong, Yongsu ;
Yoon, Jaeseung ;
Baek, Kwanghee .
CELLULAR & MOLECULAR BIOLOGY LETTERS, 2019, 24 (1)
[2]   MCL-1 is a prognostic indicator and drug target in breast cancer [J].
Campbell, Kirsteen J. ;
Dhayade, Sandeep ;
Ferrari, Nicola ;
Sims, Andrew H. ;
Johnson, Emma ;
Mason, Susan M. ;
Dickson, Ashley ;
Ryan, Kevin M. ;
Kalna, Gabriela ;
Edwards, Joanne ;
Tait, Stephen W. G. ;
Blyth, Karen .
CELL DEATH & DISEASE, 2018, 9
[3]   Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy [J].
Czabotar, Peter E. ;
Lessene, Guillaume ;
Strasser, Andreas ;
Adams, Jerry M. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (01) :49-63
[4]  
Dela Cruz R, 2011, AM J BLOOD RES, V1, P135
[5]   Dual modulation of MCL-1 and mTOR determines the response to sunitinib [J].
Elgendy, Mohamed ;
Abdel-Aziz, Amal Kamal ;
Renne, Salvatore Lorenzo ;
Bornaghi, Viviana ;
Procopio, Giuseppe ;
Colecchia, Maurizio ;
Kanesvaran, Ravindran ;
Toh, Chee Keong ;
Bossi, Daniela ;
Pallavicini, Isabella ;
Luis Perez-Gracia, Jose ;
Dolores Lozano, Maria ;
Giandomenico, Valeria ;
Mercurio, Ciro ;
Lanfrancone, Luisa ;
Fazio, Nicola ;
Nole, Franco ;
Teh, Bin Tean ;
Renne, Giuseppe ;
Minucci, Saverio .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (01) :153-168
[6]   FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation [J].
Feng, C. ;
Yang, F. ;
Wang, J. .
CANCER GENE THERAPY, 2017, 24 (08) :342-347
[7]  
Fu JD, 2019, EUR REV MED PHARMACO, V23, P155, DOI 10.26355/eurrev_201901_16759
[8]   miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma [J].
Hu, Guanghui ;
Lai, Peng ;
Liu, Min ;
Xu, Liang ;
Guo, Zhuifeng ;
Liu, Huan ;
Li, Wei ;
Wang, Gangchun ;
Yao, Xudong ;
Zheng, Junhua ;
Xu, Yunfei .
TUMOR BIOLOGY, 2014, 35 (11) :11443-11453
[9]   KRIBB11 accelerates Mcl-1 degradation through an HSF1-independent, Mule-dependent pathway in A549 non-small cell lung cancer cells [J].
Kang, Min-Jung ;
Yun, Hye Hyeon ;
Lee, Jeong-Hwa .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 492 (03) :304-309
[10]   The correlation between HIF-1 alpha and VEGF in oral squamous cell carcinomas: Expression patterns and quantitative immunohistochemical analysis [J].
Lee, Li-Tzu ;
Wong, Yong-Kie ;
Chan, Man-Yee ;
Chang, Kuo-Wei ;
Chen, Shyh-Chang ;
Chang, Chiou-Tuz ;
Wang, John .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (04) :370-375